Upload Avatar (500 x 500)
Jing Yang
yangjingliu2013@163.com
Chinese, English
Hubei
Wuhan University
Basic Medical Sciences
  • 1998-2001: PhD in Internal Medicine, Wuhan University
  • 1987-1990: Master in Pathogenic Biology, Hubei Medical University
  • 1982-1987: Bachelor in Clinical Medicine, Hubei Medical University
  • 2007-present: Professor, Deputy Head of Department, Pharmacology Department, School of Basic Medical Sciences, Wuhan University
  • 2002-2006: Associate Professor, Deputy Head of Department, Pharmacology Department, Medical School, Wuhan University
  • 2006: Research Fellow, Department of Pharmacology, Fukushima Medical University, Japan
  • 1990-1998: Physician, Senior Physician, Clinical Pharmacology Laboratory, Hubei Institute of Geriatrics
  • 2011: New Drug Certificate and Production License for Valtrate Extract and Spasmolysis Capsule (Drug Approval Number: Z20110032; Drug Registration Number: 2011S00735)
  • 2006: Third Prize, Wuhan Science and Technology Progress Award for the clinical and experimental study of Pinglv Compound in treating arrhythmia
Functional studies of important lipid metabolites in cell membranes
Innovative drug research and development
  • CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis, Yang J et al., 2017
  • Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma, Yang J et al., 2017
  • 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo, Yang J et al., 2014
  • Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6, Yang J et al., 2014
  • Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion, Yang J et al., 2014
  • Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer, Yang J et al., 2013
  • Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer, Yang J et al., 2012
  • Antitumor and immunostimulatory activity of a polysaccharide–protein complex from Scolopendra subspinipes mutilans L. Koch in tumor-bearing mice, Yang J et al., 2012
  • Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer, Yang J et al., 2011
  • Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats, Yang J et al., 2006
Lipid Metabolism Cell Membrane Tumor Angiogenesis Metastasis Arachidonic Acid Cox Lox Cyp Enzymes Biological Activity Disease Processes Drug Targets Traditional Chinese Medicine Structural Modification Pharmacodynamics Toxicology Multi-Target Drugs Synergistic Effects Side Effects Drug Development Clinical Trials

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.